Detalhe da pesquisa
1.
Identifying Contextual and Spatial Risk Factors for Post-Acute Sequelae of SARS-CoV-2 Infection: An EHR-based Cohort Study from the RECOVER Program
Preprint
em Inglês
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22281010
2.
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial (HERO-HCQ)
Preprint
em Inglês
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21262275
3.
Characteristics of 24,516 Patients Diagnosed with COVID-19 Illness in a National Clinical Research Network: Results from PCORnet
Preprint
em Inglês
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20163733
4.
Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Preprint
em Inglês
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22283488
5.
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Preprint
em Inglês
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22281178